MODEL VERDICT
PureTech Health plc (PRTC) — Relative Valuation
Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
Each row records the model's monthly assessment. High Conviction = the model detected notable undervaluation vs peers. Neutral = no notable divergence was found. The return column shows the actual price change over 90 days for reference. This is a quantitative observation log — not investment advice.
| Date | Assessment | Score | Price | Status | 90d Fwd Return |
|---|---|---|---|---|---|
| Feb 28, 2026 | MODERATE | 0.63 | $16.77 | CURRENT | — |
| Feb 21, 2026 | MODERATE | 0.63 | $17.61 | CURRENT | — |
| Feb 14, 2026 | MODERATE | 0.63 | $17.46 | CURRENT | — |
| Feb 11, 2026 | MODERATE | 0.63 | $17.46 | CURRENT | — |
| Jan 11, 2026 | MODERATE | 0.66 | $17.60 | Pending | +0.1% |
Historical model observations for research purposes only. Past quantitative patterns do not predict future results. Not a recommendation to buy, sell, or hold any security.
| Methodology | Fair Value | vs Current | Weight | Quality | Status |
|---|---|---|---|---|---|
| Industry Median P/E 48 industry peers | $43.61 | +160.0% | 15% | A | Peer Data |
| EV To Revenue 130 industry peers | $11.75 | -29.9% | 4% | B | Data |
| Price / Sales 130 industry peers | $2.16 | -87.1% | 3% | B | Model Driven |
| Earnings Yield 47 industry peers | $53.09 | +216.6% | 2% | B | Data |
| Weighted Output Blended model output | $33.52 | +99.9% | 100% | 60 | SIGNIFICANTLY UNDERVALUED |
| EPS Growth ↓ | P/E Multiple → | 4× | 6× | 8× (Current) | 10× | 12× |
|---|---|---|---|---|---|
| Bear Case (2%) | $8 | $12 | $16 | $20 | $24 |
| Conservative (5%) | $8 | $13 | $17 | $21 | $25 |
| Base Case (-32.6%) | $5 | $8 | $11 | $13 | $16 |
| Bull Case (-44%) | $4 | $7 | $9 | $11 | $13 |
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
| Multiple | Avg | Median | Min | Max | Std |
|---|---|---|---|---|---|
| EV/EBIT | 20.90 | 22.38 | 7.08 | 33.23 | 13.13 |
| P/TBV | 1.77 | 1.70 | 1.22 | 2.42 | 0.43 |
| P/B Ratio | 1.76 | 1.70 | 1.22 | 2.42 | 0.43 |
| P/S Ratio | 213.48 | 189.60 | 103.10 | 434.63 | 135.62 |
Based on our peer multiples analysis with 9 valuation metrics, the model estimates PRTC's fair value at $33.52 vs the current price of $16.77, implying +99.9% upside potential. Model verdict: Significantly Undervalued. Confidence: 60/100. This is a quantitative estimate, not a recommendation.
The blended fair value of $33.52 is calculated using four lenses: industry median multiples (40%), historical multiples (30%), forward estimates (20%), and quality-adjusted multiples (10%). Monte Carlo simulation (10,000 iterations) gives a range of $11.38 (P10) to $68.53 (P90), with a median of $37.80.
PRTC's current P/E of 8.4x compares to the industry median of 21.8x (48 peers in the group). This represents a -61.5% discount to the industry. The historical average P/E is N/Ax over 0 years. Signal: Deep Discount.
2 analysts cover PRTC with a consensus rating of Buy. The consensus price target is $57.00 (range: $44.00 — $70.00), implying +239.9% upside from the current price. Grade breakdown: Strong Buy (0), Buy (2), Hold (0), Sell (0), Strong Sell (0).
The model confidence score is 60/100, based on: data completeness (12), peer quality (25), historical depth (16), earnings stability (5), and model agreement (2). Cyclicality penalty: -0 points. The model shows moderate agreement across inputs.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk data is not available for PRTC.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.